Summary Agaricus blazei Murill is a mushroom largely consumed due to its medicinal properties. Effects of aqueous extract from its lineage AB97/11 in 2 fruiting body development stages (closed and opened pileus) were evaluated on chinese hamster V79 cells using cytokinesis blocking micronucleus (CBMN) and comet assays. The cells were treated at 0.15% concentration of aqueous extract prepared at different temperatures: ice-cold (4°C), room temperature (21°C) and warm (60°C). The extracts were applied in mutagenicity and antimutagenicity protocols (simultaneous, pre-incubation and continuous). The results showed that the aqueous extracts of Agaricus blazei lineage AB97/11 obtained at the 3 temperatures and both development stages did not present mutagenic or antimutagenic effect in V79 cells either in CBMN or comet assay.
Materials and methods

Sun mushroom aqueous extracts
Dehydrated fruiting body of the A. blazei lineage AB97/11 in 2 development stages (closed and opened pileus) was produced and supplied by the Faculty of Agronomic Sciences-UNESP, Botucatu, São Paulo, Brazil. After agitating, the aqueous solutions obtained by diluting 5 g of the fruiting body pound in 200 ml distilled water for 10 min, were incubated at 3 different temperatures: (a) ice-cold (4°C) for 1 h; (b) room temperature (21°C) for 2 h and warm (60°C) for 5 min and filtered after cooling for 15 min at room temperature. The solutions were initially filtered in common filter paper and later sterilized in 0.2 mm bacteriological filter membrane. Aliquots were frozen for later use at room temperature. Each extract was applied to cell cultures at the final dilution of 0.15% (300 µl in 5 ml culture).
Mutagenic agent
The alkylating agent methyl methanesulphonate (MMS), used as a DNA damage inducer, was freshly dissolved in Ca ϩϩ and Mg ϩϩ free phosphate buffer saline (PBS) pH 7.4. Different MMS concentrations were used depending on the cell treatment protocol and each concentration was chosen from tests carried out in our laboratory (4ϫ10 Ϫ4 M or 10 Ϫ4 M in CBMN and 1.2ϫ10 Ϫ4 M in comet assay) using the DNA damage induction that no promoted cytotoxicity as selection criteria.
Cell culture and treatment
V79 cells (chinese hamster lung fibroblast) supplied by the Laboratory of Mutagenesis of USP (Riberão Preto, São Paulo, Brazil) were grown in culture flasks, in Ham's F10 culture medium plus Dulbecco's modified Eagle minimum essential medium (1 : 1) with 0.1% antibiotic-antimicotic solution, supplemented with 10% fetal bovine serum in a BOD type incubator at 37°C. The average cell cycle time of V79 was 12-14 h under these conditions. For both assays the cells were cultivated for 2 cell cycles (25 h) in complete culture medium before being treated according to one of the following treatment protocols (1) treatment with each extract at the 0.15% final concentration for 1 h (mutagenicity); (2) co-treatment with each extract and MMS for 1 h (simultaneous); (3) treatment with the mixture of each extract with MMS that after resting for 1 h was applied in culture for 1 h (pre-incubation); (4) co-treatment with each extract with MMS for 18 h (continuous). For each protocol there were (a) one culture treated with phosphate-buffered saline (PBS, pH 7.4) (negative control) and (b) a culture treated with alkylating agent MMS at the final concentrations of 4ϫ10 Ϫ4 M for mutagenicity, simultaneous and pre-incubation, 10 Ϫ4 M for 3 simultaneous continuous (CBMN) and 1.2ϫ10 Ϫ4 M for the comet assay. The continuous mutagenicity protocol was not performed in the comet assay. All treatments described here were repeated independently 3 times for both assays.
Cytokinesis block micronucleus assay
The agents were added to 5 ml of complete culture medium 25 h after iniciating the cultive of cells which had been previously seeded in 25 cm 3 flasks. At the end of the treatments of mutagenicity, simultaneous and pre-incubation, the cells were washed twice with 5 ml of PBS (pH 7.4) at room temperature. After, this flasks received 5 ml of new complete culture medium with cytochalasin-B (3 µg/ml). The cells were cultivated for further 17 h to block cytokinesis and to yield binucleated cells. In the continuous treatment protocol the cells were not washed and cytochalasin-B was add 1 h after beginning of the treatment.
For harvesting the cells were trypsinized (0.025% trypsin at room temperature), hypotonized (1% sodium citrate) and fixed with methanol/acetic acid (3 : 1). The slides were stained with 5% Giemsa dissolved in phosphate buffer (0.06 M Na 2 HPO 4 , 0.039 M KH 2 PO 4 , pH 7.0) for 5 min and analyzed.
One thousand binucleated cells per treatment were analyzed for each experimental repetition. Only cells with conserved cytoplasm were scored. The following criteria were used to identify the micronuclei (MN) ( Fig. 1): (1) MN should be smaller than 1/3 of the nucleus; (2) both MN and the nucleus should be round; (3) MN could not present connection with the nucleus; and (4) MN should not be refractive and should have coloring similar to the nucleus (Schmid 1976 , TitenkoHolland et al. 1997 .
Single cell gel electrophoresis assay
General procedures according to Speit and Hartmann (1999) , were used for the comet assay with modifications.
The V79 cells were seeded in flasks with 2.5 ml of complete culture medium, cultivated for 25 h and treated for 1 h applying genotoxicity, simultaneous and pre-incubation protocols. When the treatment had finished, the cells were trypsinized (200 µl 0.025% trypsin), centrifuged and re-suspended in culture medium (500 µl) after centrifugation. The cell suspension (10 µl) was mixed with 120 µl LMP (low melting point) agarose (0.5%) at 37°C and spread onto microscope slides precoated with 1.5% normal agarose. Coverslips were added to the slides and allowed to gel at 4°C for 10 min. After removing the coverslips, the slides were immersed in recently prepared lysing solution, composed of 89 ml solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, pH 10 corrected with solid NaOH, 890 ml distilled water, 1% sodium Na-lauroyl sarcosine), 1ml Triton X-100 and 10 ml DMSO. Cellular lyse occurred in refrigerator 4°C, protected from the light, for 1 h. The slides were taken to the electrophoresis cube with pH Ͼ13.0 buffer (300 mM NaOH, 1 mM EDTA, prepared from a stock solution of NaOH 1ON, EDTA 200 mM, pH 10.0) at 4°C for 20 min for DNA denaturation. Electrophoresis was performed at 4°C for 20 min, 25 V and 300 mA (1.6 V/cm). Later the slides were neutralized with pH 7.5 buffer (0.4 M Tris-HCl) for 15 min (3 cycles of 5 min), dried and fixed in 100% ethyl alcohol for 10 min and kept up to reading. The slides were covered with 50 µl ethidium bromide 200 µg/ml and coverslip for staining. The material was assessed under a fluorescence microscope at 400ϫ magnification, with 420-490 nm excitation filter and 520 nm barrier filter.
One hundred cells per treatment were analyzed visually (Kobayashi et al. 1995) , for each experimental repetition, classifying the comets as: (class 0) cells with undetectable DNA damage that did not present tail; (class 1) cells with tail smaller than the diameter of the nucleus; (class 2) cells with tail length between once and twice the nucleus diameter; (class 3) cells with tail longer than twice the nucleus diameter (Fig. 2) . Apoptotic cells that presented nucleus totally fragmented were not scored (Speit and Hartmann 1999) .
Statistical analysis
The results of the 3 independent repetitions for both assays were summed and the statistical differences between treatments and controls were determined by the χ 2 test (Pereira 1991) . 
Results and discussion
Biological data on the medicinal properties associated with mushrooms are rare, especially regarding antimutagenic and anticarcinogenic activities (Grüter et al. 1990 ). As the use of A. blazei is very popular and it has been prepared in diverse temperature conditions, 3 aqueous extraction temperatures were tested (4, 21, 60°C) in the present study. Our results showed that the aqueous extracts of the A. blazei lineage AB97/11 did not have mutagenic or genotoxic effect at the 0.15% concentration regardless of the temperature of extraction. The results of the mutagenicity or genotoxicity with A. blazei extracts are shown in Table 1 . The fruiting body development phase also did not interfere in this biological response, suggesting that there is no significant presence of water soluble mutagenic substances either in this closed and opened pileus phases of development. Table 2 show the results of the antimutagenicity in the CBMN assay. The extracts were not able to reduce significantly the cell number with MN in relation to the MMS in any of the cases. ther in relation to the number of damaged cells or to the level of damage observed (class types).
Geographic, climatic and intra specific variations may interfere in mushroom biological response (Chang 1996) and this type of interfering on its antimutagenic effect should be studied in A. blazei. Further to these factors, harvesting and conservation methods of this mushroom may promote loss or degradation of active compounds. The presence of antimutagenic potential in A. blazei cannot be excluded since may be that an incomplete extraction of the active components may occurs according to solvent used in the extraction. Thus, organic extracts should also be assessed.
However, Oliveira et al. (2002) demonstrated activity desmutagenic and bioantimutagenic to aqueous extracts by A. blazei. Desmutagenic are those compounds able to prevent mutagenic action mainly by trapping the mutagenic agents and acting outside the cell. Bioantimutagenic agents are those able to prevent the lesion or to stimulate the DNA repair mechanisms, acting inside the cell (Kada and Shimoi 1987) . Different treatment protocols have been used in an attempt to elucidate antimutagenicity mechanisms (De Flora 1998) . In the present study, 3 protocols that can demon- 
